Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Pui

Showing results (71-80 of 414) with videos related to

Pageof 42
Sort By:
Current Opinion in Molecular Therapeutics|January 24, 2002
Pharmacogenomics of childhood acute lymphoblastic leukemiaT L Brenner, C H Pui, W E Evan
Leukemia|January 1, 1993
Expression of activation antigens CD38 and CD71 is not clinically important in childhood acute lymphoblastic leukemiaM Koehler, F Behm, M Hancock, et al.
Cancer Research|November 1, 1982
Glucocorticoid receptors in childhood acute lymphocytic leukemiaM E Costlow, C H Pui, G V Dahl
Leukemia|May 1, 1995
Biology and treatment of infant leukemiasC H Pui, J R Kane, W M Crist
Blood|October 15, 1990
Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemiaC H Pui, W M Crist, A T Look
Cancer|February 1, 1988
Vertebral compression fracture as a presenting feature of acute lymphoblastic leukemia in childrenR C Ribeiro, C H Pui, M J Schell
Leukemia|August 11, 1998
Meeting report: International Childhood ALL Workshop: Memphis, TN, 3-4 December 1997C H Pui, W E Evans, J R Gilbert
Leukemia|April 1, 1988
Isochromosome 17q in childhood acute lymphoblastic leukemia: an adverse cytogenetic feature in association with hyperdiploidy?C H Pui, S C Raimondi, D L Williams
Anales Espanoles De Pediatria|October 1, 1988
Clinical and biological features predict relapse hazard in childhood acute lymphoid leukemiaW M Crist, W Furman, M Roberts, et al.
Southern Medical Journal|July 1, 1987
Acute lymphocytic leukemia in childhood: immunologic marker, cytogenetic, and molecular studiesW M Crist, W Furman, D Strother, et al.
Pageof 42

Showing results (71-80 of 414) with videos related to

Sort By:
Pageof 42
Current Opinion in Molecular Therapeutics|January 24, 2002
Pharmacogenomics of childhood acute lymphoblastic leukemiaT L Brenner, C H Pui, W E Evan
Leukemia|January 1, 1993
Expression of activation antigens CD38 and CD71 is not clinically important in childhood acute lymphoblastic leukemiaM Koehler, F Behm, M Hancock, et al.
Cancer Research|November 1, 1982
Glucocorticoid receptors in childhood acute lymphocytic leukemiaM E Costlow, C H Pui, G V Dahl
Leukemia|May 1, 1995
Biology and treatment of infant leukemiasC H Pui, J R Kane, W M Crist
Blood|October 15, 1990
Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemiaC H Pui, W M Crist, A T Look
Cancer|February 1, 1988
Vertebral compression fracture as a presenting feature of acute lymphoblastic leukemia in childrenR C Ribeiro, C H Pui, M J Schell
Leukemia|August 11, 1998
Meeting report: International Childhood ALL Workshop: Memphis, TN, 3-4 December 1997C H Pui, W E Evans, J R Gilbert
Leukemia|April 1, 1988
Isochromosome 17q in childhood acute lymphoblastic leukemia: an adverse cytogenetic feature in association with hyperdiploidy?C H Pui, S C Raimondi, D L Williams
Anales Espanoles De Pediatria|October 1, 1988
Clinical and biological features predict relapse hazard in childhood acute lymphoid leukemiaW M Crist, W Furman, M Roberts, et al.
Southern Medical Journal|July 1, 1987
Acute lymphocytic leukemia in childhood: immunologic marker, cytogenetic, and molecular studiesW M Crist, W Furman, D Strother, et al.
Pageof 42